Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation
about
Bioactive Molecules Released From Cells Infected with the Human CytomegalovirusViral Evasion of Natural Killer Cell ActivationPartners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV InfectionDistinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients.HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells.Genetics, genomics, and evolutionary biology of NKG2D ligands.Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies.NKG2D Receptor and Its Ligands in Host DefenseHigh-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.A cluster of 3' coterminal transcripts from US12-US17 locus of human cytomegalovirus.Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusInactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial Cells.Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinomaT Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology.Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility GenesDisarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.The use of microRNA by human viruses: lessons from NK cells and HCMV infection.Cytomegalovirus immune evasion by perturbation of endosomal trafficking.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?Human cytomegalovirus: taking the strain.Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer.Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and ToledoDistinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro.Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a.Viral inhibitors of NKG2D ligands for tumor surveillance.Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20.Exploring and Exploiting Proteome Organization during Viral Infection.A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus InfectionInduction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK CellsOrigins of Natural Killer Cell Memory: Special Creation or Adaptive Evolution.CMV and natural killer cells: shaping the response to vaccination.
P2860
Q26744665-C0FE451F-B19D-4681-AA35-AC6E197F3661Q26748421-5D7D1A9B-C63D-4362-B7B3-FFC276784995Q28079533-8BA1AE85-1BE7-4D3A-9E83-4F57D2085C9EQ33776574-C6FFBA2B-8BAF-4BCC-81A3-71FE6671FDA9Q34116205-925DFB4B-C51C-46F6-B73F-958F89DFF34DQ34489980-BAF127C3-7739-4150-AE1E-A037177C1773Q34526520-591F0033-9176-4010-B0F5-D9FE8636B5FBQ35541002-866F8431-C999-4DF6-ADFC-1B80203D7EC7Q35687826-F654F72E-6CAE-4DBC-B281-656AA7B2C7A8Q35861195-525D0B75-C1A4-4178-B828-C58E81DDFAB8Q35861220-3C6CCC97-7BD4-4376-95FC-F71AA81FFF05Q35941760-F375A9A9-9BEB-46BC-837B-FC9E4566CEE5Q36118554-FAA13009-6880-4BAC-B411-F6ADB25826CDQ36208168-83DDA86D-7AEA-4DF5-91A1-319AB423047FQ36736566-BFA645EF-F17A-4D57-B9E2-6F627E60ED07Q37065966-78EBDB45-BFA1-42B6-8F52-63AEEEE83AF3Q37225207-5497A395-B4B2-4B7C-8CEE-83B5DB8765BAQ37598020-26D9B8D7-A026-469C-B0EA-840330B4BF05Q37622486-D4FB395F-4413-4974-B8C5-1CE0D10B8C30Q37723095-5D34E906-D645-4C15-AEEA-C0CB0B0997F8Q37734489-79C785B8-A79D-429C-93FF-392B16698515Q37747044-775FFC2E-0815-43C3-822B-7DD3CC658F60Q38252422-BF10E60D-D529-4864-8085-FC84ACB12892Q38255071-EEF178C6-FE06-4231-A024-6519574B156AQ38270735-899CCF13-F8B0-4AB6-B7E4-DC3546721540Q38430703-260AD52E-C6A6-4EBC-959F-32C4BCF192C2Q38711117-8F88626D-E4B8-4665-9CF5-F59EE555BC33Q38732965-143083FD-56D0-43AF-A46F-FA3DEC05201DQ38741498-7379EDCC-2A56-4308-A815-256AFC50EFCDQ38796870-D8F6697E-319D-494D-B5A3-208225C5A6DCQ38798990-826CABCE-D0DF-4B62-AE85-7CF428639461Q38818598-40E4ABE4-77EF-4D9B-87BE-94AD3B6BD1F4Q38870478-E7A731CC-02AD-4F19-9423-A8B9A710B98CQ40078923-CBB2464E-4A1C-4E73-BCD2-AE2F5623B7BEQ40134094-579CB386-B32C-4EF0-8CAE-72EA2AD31D5DQ40483606-3196570A-E14F-4E46-9088-35FFFA69D230Q40922609-85BF2D3B-23FF-42C3-80B7-385F58C5F43CQ41482457-2BAAEED8-07A1-4A74-86FE-31F87DD3F567Q47550532-D56E226C-6620-480F-AB4A-C7616FC510AEQ48273032-3A17FDE1-139E-4261-B2F5-C36CB4CCBB0F
P2860
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@ast
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@en
Two novel human cytomegaloviru ...... ICA for lysosomal degradation.
@nl
type
label
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@ast
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@en
Two novel human cytomegaloviru ...... ICA for lysosomal degradation.
@nl
prefLabel
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@ast
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@en
Two novel human cytomegaloviru ...... ICA for lysosomal degradation.
@nl
P2093
P2860
P50
P1433
P1476
Two novel human cytomegaloviru ...... MICA for lysosomal degradation
@en
P2093
Andrew J Davison
Daniel Sugrue
Dawn Roberts
Gavin W G Wilkinson
P Robin Antrobus
Peter Tomasec
Rebecca Aicheler
Sepehr Seirafian
Simone Cuff
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004058
P50
P577
2014-05-01T00:00:00Z